COVID-19 UPDATE: We are open! Our team is working and offering consultations via phone, e-mail, and video conferencing.
(251) 299-0101

Zantac®Lawsuit Attorneys in Alabama

Representing Nationwide Victims of the Defective drug Zantac®

On September 9, 2019, Valisure, an online pharmacy licensed in 38 states, submitted a “Citizen Petition” to the FDA asking the regulatory agency to request a recall and suspend sales of ranitidine, a popular drug commonly sold under the brand name Zantac®.

Valisure detected “extremely high levels” of N-Nitrososdimethylamine (“NDMA”), a probable human carcinogen, “in every lot tested, across multiple manufacturers and dosage forms of the drug ranitidine [Zantac®].” The FDA’s daily intake limit for the carcinogen NDMA is 96 ng. Valisure detected NDMA in excess of 3,000,000 ng per tablet of Zantac®. Valisure’s testing showed that a single Zantac® tablet contains the same amount of NDMA as 30 packs of cigarettes.

Within 4 days of receiving Valisure’s Citizen Petition, the FDA notified the public that NDMA had been found in ranitidine medicines, including Zantac®. Within weeks, manufacturers, distributors, and retailers of Zantac® issued nationwide recalls.

Early investigation raises concerns that pharmaceutical companies knew that Zantac® greatly increased a person’s likelihood of developing cancer but altered the science to hide the association between Zantac® and NDMA.

Exposure to NDMA is associated with the following cancers:

  • Bladder cancer
  • Breast cancer
  • Colorectal/intestinal cancer
  • Esophageal cancer
  • Gastric/Stomach cancer
  • Kidney cancer
  • Liver cancer
  • Lung cancer
  • Pancreatic cancer
  • Prostate cancer

If you or a loved one took brand name Zantac® or the generic (ranitidine) – whether by prescription or over the counter – and developed cancer, contact us to speak with our lawyers about a lawsuit. Despite being told for decades that Zantac® was safe, millions of Americans have been harmed by this deadly drug. We will fight for you and your family.

Cunningham Bounds has been representing plaintiffs for over 60 years. The firm has achieved a national reputation as a result of its trial expertise and precedent-setting verdicts for its clients throughout the United States. The attorneys of Cunningham Bounds routinely go head-to-head with some of the best defense attorneys in the country. They have obtained multi-million – and even multi-billion – dollar verdicts against national and international corporations including: Exxon, Ineos Phenol, Hobart Corporation, Rheem Manufacturing, General Motors Corporation, Ford Motor Company, Aetna Life & Casualty Company, ShawCor Ltd., Halliburton, Target Corporation, Kia Motors of America, Mack Trucks, Mobil Oil Company, and General Motors. Cunningham Bounds has a reputation of being one of the toughest firms to beat. Our attorneys work tirelessly to achieve the best possible result for each client, and the firm’s impressive record of verdicts and settlements proves it.


  • How We Select Our Cases
  • Legal Update - The History of Cunningham Bounds, Part 1
  • Legal Update - The History of Cunningham Bounds, Part 2
See More Videos


See More Blogs
  • Just the name of the firm ‘sends fear into the hearts of the defense.

    - Attorney, Mobile Bay Monthly
  • It’s a small, elite shop of some of the best lawyers in the business.

    - Benchmark Litigation: The Definitive Guide to Americas Leading Litigation Firms and Attorneys
  • The firm’s personal injury practice maintains a stellar reputation

    - Benchmark Litigation: The Definitive Guide to Americas Leading Litigation Firms and Attorneys
  • They are either right at being the best plaintiff lawyers in the nation or certainly equal to it.

    - Defense Trial Lawyer Norman Waldrop, quoted in the Mobile Register newspaper
  • A premier plaintiff firm in the state.

    - Chambers and Partners USA
  • These guys are just that good.

    - Benchmark Litigation: The Definitive Guide to Americas Leading Litigation Firms and Attorneys

Contact Us Today

  • Please enter your name.
  • This isn't a valid email address.
    Please enter your email.
  • This isn't a valid phone number.
    Please enter your phone number.
    You entered an invalid number.
  • Please make a selection.
  • Please enter a message.